Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$1.43 | -$1.37 | -$1.40 |
| Q2 2025 | 1 | -$1.41 | -$1.35 | -$1.38 |
| Q3 2025 | 3 | -$1.52 | -$1.46 | -$1.49 |
| Q4 2025 | 3 | -$0.96 | -$0.93 | -$0.94 |
| Q1 2026 | 2 | -$0.79 | -$0.76 | -$0.77 |
| Q2 2026 | 1 | -$0.69 | -$0.66 | -$0.68 |
| Q3 2026 | 1 | -$0.62 | -$0.59 | -$0.60 |
| Q4 2026 | 1 | -$0.44 | -$0.42 | -$0.43 |
Biodesix, Inc. last posted its earnings results on Monday, November 3rd, 2025. The company reported $-1.16 earnings per share for the quarter, topping analysts' consensus estimates of $-1.6 by $0.44. The company had revenue of 21.77 M for the quarter and had revenue of 71.32 M for the year. Biodesix, Inc. has generated $-7 earnings per share over the last year ($-6.6 diluted earnings per share) and currently has a price-to-earnings ratio of -1.46. Biodesix, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 30th, 2025 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/03/2025 | Q3 2025 | -$1.60 | -$1.16 | 0.44 | $20.97 M | $21.77 M |
| 08/07/2025 | Q2 2025 | -$1.40 | -$1.60 | -0.2 | $18.57 M | $20.02 M |
| 05/13/2025 | Q1 2025 | -$0.08 | -$1.60 | -1.52 | N/A | $17.96 M |
| 03/03/2025 | Q4 2024 | -$0.07 | -$1.20 | -1.13 | N/A | $20.43 M |
| 11/01/2024 | Q3 2024 | -$0.08 | -$1.40 | -1.32 | $18.57 M | $18.15 M |
| 08/07/2024 | Q2 2024 | -$0.09 | -$1.60 | -1.51 | $16.13 M | $17.93 M |
| 05/08/2024 | Q1 2024 | -$0.15 | -$0.14 | 0.01 | N/A | $14.82 M |
| 03/01/2024 | Q4 2023 | -$0.11 | -$1.98 | -1.87 | N/A | $14.67 M |
| 11/07/2023 | Q3 2023 | -$0.15 | -$0.14 | 0.01 | $14.12 M | $13.49 M |
| 08/07/2023 | Q2 2023 | -$0.21 | -$0.17 | 0.04 | $11.67 M | $11.87 M |
| 05/11/2023 | Q1 2023 | -$0.26 | -$0.24 | 0.02 | $8.71 M | $9.06 M |
| 03/06/2023 | Q4 2022 | -$0.26 | -$0.35 | -0.09 | $10.77 M | $9.61 M |
| 11/03/2022 | Q3 2022 | -$0.32 | -$0.34 | -0.02 | $10.15 M | $11.11 M |
| 08/04/2022 | Q2 2022 | -$0.47 | -$0.40 | 0.07 | $8.83 M | $10.95 M |
| 05/11/2022 | Q1 2022 | -$0.38 | -$0.50 | -0.12 | $6.47 M | $6.55 M |
| 03/14/2022 | Q4 2021 | -$0.50 | -$0.49 | 0.01 | $7.29 M | $7.22 M |
| 11/15/2021 | Q3 2021 | -$0.50 | -$8.20 | -7.7 | $6.15 M | $6.53 M |
| 08/10/2021 | Q2 2021 | -$0.31 | -$0.41 | -0.1 | $20.58 M | $11.89 M |
| 05/11/2021 | Q1 2021 | -$0.13 | -$0.26 | -0.13 | $26.23 M | $28.87 M |
| 03/16/2021 | Q4 2020 | -$0.48 | -$0.25 | 0.23 | $15.47 M | $27.03 M |
Biodesix, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, October 30th, 2025 based offlast year's report dates.
In the previous quarter, Biodesix, Inc. (:BDSX) reported $-1.16 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.6 by $0.44.
The conference call for Biodesix, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Biodesix, Inc.'s latest earnings report can be read online.
Biodesix, Inc. (:BDSX) has a recorded annual revenue of $71.32 M.
Biodesix, Inc. (:BDSX) has a recorded net income of $-42,931,000.Biodesix, Inc. has generated $-6.6 earnings per share over the last four quarters.
Biodesix, Inc. (:BDSX) has a price-to-earnings ratio of -1.46 and price/earnings-to-growth ratio is -0.35.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED